Capital Advisors Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.2M | Buy |
11,872
+248
| +2% | +$46K | 0.35% | 56 |
|
2025
Q1 | $2.44M | Sell |
11,624
-16
| -0.1% | -$3.35K | 0.43% | 46 |
|
2024
Q4 | $2.07M | Buy |
11,640
+248
| +2% | +$44.1K | 0.37% | 47 |
|
2024
Q3 | $2.25M | Buy |
11,392
+106
| +0.9% | +$20.9K | 0.41% | 44 |
|
2024
Q2 | $1.94M | Buy |
11,286
+990
| +10% | +$170K | 0.38% | 45 |
|
2024
Q1 | $1.87M | Sell |
10,296
-3,679
| -26% | -$670K | 0.39% | 43 |
|
2023
Q4 | $2.17M | Buy |
13,975
+625
| +5% | +$96.9K | 0.49% | 39 |
|
2023
Q3 | $1.99M | Buy |
13,350
+1,042
| +8% | +$155K | 0.52% | 37 |
|
2023
Q2 | $1.66M | Buy |
12,308
+514
| +4% | +$69.3K | 0.42% | 47 |
|
2023
Q1 | $1.88M | Buy |
11,794
+748
| +7% | +$119K | 0.52% | 41 |
|
2022
Q4 | $1.79M | Buy |
11,046
+1,354
| +14% | +$219K | 0.54% | 34 |
|
2022
Q3 | $1.3M | Buy |
9,692
+4,995
| +106% | +$671K | 0.43% | 40 |
|
2022
Q2 | $719K | Buy |
4,697
+655
| +16% | +$100K | 0.23% | 48 |
|
2022
Q1 | $655K | Buy |
4,042
+577
| +17% | +$93.5K | 0.2% | 59 |
|
2021
Q4 | $469K | Buy |
3,465
+1,550
| +81% | +$210K | 0.14% | 69 |
|
2021
Q3 | $207K | Buy |
+1,915
| New | +$207K | 0.07% | 98 |
|